Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectability. Dickerson K, Milas M, Metzger R, Tomeh C, et al. Surgery 2024 Oct 28:S0039-6060(24)00706-2. doi: 10.1016/j.surg.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Dickerson K, Milas M, Metzger R, Tomeh C, et al. Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectability. Surgery 2024 Oct 28:S0039-6060(24)00706-2. doi: 10.1016/j.surg.2024.
PMID: 39472260